Krka Cleared of Patent Infringement in Norway
Oslo/Novo Mesto, 27 June - The Oslo District Court ruled that Slovenian pharma company Krka does not violate the patent of the US pharma company MSD for manufacturing losartan, a drug used mainly to treat high blood pressure, in Norway. The MSD still has the right to appeal, Krka said in a press release on Friday.
The rest of this news item is available to subscribers.
The news item consists of 648 characters (without spaces) or 135 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.